Delayed hemolytic transfusion reaction in the French hemovigilance system

被引：7
作者：
Rieux, C. [1 ]
Brittenham, G. [2 ]
Bachir, D. [3 ]
De Meyer, E. [1 ]
Boudjedir, K. [4 ]
机构：
[1] CHU Henri Mondor, Unite Hemovigilance & Securite Transfus, F-94010 Creteil, France
[2] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA
[3] CHU Henri Mondor, Ctr Reference Syndromes Drepanocytaires Majeurs, F-94010 Creteil, France
[4] Agence Natl Securite Medicament & Prod Sante ANSM, F-93285 St Denis, France
来源：
TRANSFUSION CLINIQUE ET BIOLOGIQUE | 2019年 / 26卷 / 02期
关键词：
Hemovigilance; Delayed hemolytic transfusion reactions; Sickle-cell disease;
D O I：
10.1016/j.tracli.2019.03.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In France, reporting of adverse events related, or likely to be related, to transfusion is mandatory. Since its creation in 1993, the French hemovigilance system has contributed to a better recognition of unappreciated risks like delayed hemolytic transfusion reactions (DHTR) in sickle-cell disease (SCD) patients. Long under-reported or misclassified, reports of this serious complication of transfusion have improved, particularly through the dissemination of information within the hemovigilance network. To our knowledge, the French hemovigilance system has one of the largest series of DHTR in SCD patients. Guidelines for diagnosis and reporting to hemovigilance system as well as a specific reporting form are being developed, which should contribute to the quality of data essential for epidemiological studies. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：109 / 111
页数：3
相关论文
共 50 条
  • [41] Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module
    Haass, Kathryn A.
    Sapiano, Mathew R. P.
    Savinkina, Alexandra
    Kuehnert, Matthew J.
    Basavaraju, Sridhar V.
    TRANSFUSION MEDICINE REVIEWS, 2019, 33 (02) : 84 - 91
  • [42] Fatal Delayed Haemolytic Transfusion Reaction and Hyperhaemolysis Syndrome in a Pregnant Woman with Sickle Cell Anaemia
    Asral Wirda Ahmad Asnawi
    Jameela Sathar
    Rashidah Mohamed
    Rohayu Deraman
    Sri Kumaran
    Shahada Sobah Abd Hamid
    Muhd Zanapiah Zakaria
    Indian Journal of Hematology and Blood Transfusion, 2016, 32 : 251 - 253
  • [43] Fatal Delayed Haemolytic Transfusion Reaction and Hyperhaemolysis Syndrome in a Pregnant Woman with Sickle Cell Anaemia
    Asnawi, Asral Wirda Ahmad
    Sathar, Jameela
    Mohamed, Rashidah
    Deraman, Rohayu
    Kumaran, Sri
    Abd Hamid, Shahada Sobah
    Zakaria, Muhd Zanapiah
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2016, 32 : S251 - S253
  • [44] Severe Hemolytic Transfusion Reaction Due to Anti-D in a D plus Patient With Sickle Cell Disease
    Ipe, Tina S.
    Wilkes, Jennifer J.
    Hartung, Helge D.
    Westhoff, Connie M.
    Chou, Stella T.
    Friedman, David F.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (02) : E135 - E137
  • [45] Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience
    Vidler, Jennifer B.
    Gardner, Kate
    Amenyah, Kenneth
    Mijovic, Aleksandar
    Thein, Swee L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (05) : 746 - 753
  • [46] The Incidence Rate of Acute Transfusion Reactions in Thalassemia Patients Referred to the Shiraz Thalassemia Centre, Shiraz, Iran, Before and After the Establishment of the Hemovigilance System
    Kasraian, Leila
    Karimi, Mohammad H.
    HEMOGLOBIN, 2015, 39 (04) : 274 - 280
  • [47] Active Hemovigilance Significantly Improves Reporting of Acute Non-infectious Adverse Reactions to Blood Transfusion
    Agnihotri, Naveen
    Agnihotri, Ajju
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2016, 32 (03) : 335 - 342
  • [48] Analysis of Transfusion-Transmitted Bacterial Infections according to German Hemovigilance Data (2011-2020)
    Orru, Stefano
    Oberle, Doris
    Heiden, Margarethe
    Mueller, Susanne
    Krut, Oleg
    Funk, Markus Benedikt
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2023, 50 (02) : 144 - 153
  • [49] Evaluation of measures aimed to reduce serious adverse transfusion reactions (hemovigilance data from 1997 to 2008)
    Funk, M. B.
    Guenay, S.
    Lohmann, A.
    Henseler, O.
    Keller-Stanislawski, B.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2010, 53 (04) : 347 - 356
  • [50] The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease
    Noizat-Pirenne, F.
    Habibi, A.
    Mekontso-Dessap, A.
    Razazi, K.
    Chadebech, P.
    Mahevas, M.
    Vingert, B.
    Bierling, P.
    Galacteros, F.
    Bartolucci, P.
    Michel, M.
    VOX SANGUINIS, 2015, 108 (03) : 262 - 267
12345